Larry Biegelsen
Stock Analyst at Wells Fargo
(4.04)
# 1,739
Out of 5,085 analysts
1361
Total ratings
52.7%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Buy | $28 | $17.85 | +56.86% | 2 | Oct 28, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $112 → $120 | $102.64 | +16.91% | 118 | Oct 23, 2026 | |
| IART Integra LifeSciences Holdings | Rated: Hold | $15 → $13 | $12.24 | +6.21% | 16 | Oct 22, 2026 | |
| ISRG Intuitive Surgical | Rated: Buy | $487 → $486 | $444.18 | +9.42% | 62 | Oct 21, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $282 → $287 | $271.04 | +5.89% | 101 | Oct 15, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $28 | $29.87 | -6.26% | 7 | Oct 15, 2026 | |
| DXCM DexCom | Reiterated: Buy | $90 | $78.62 | +14.47% | 66 | Oct 14, 2026 | |
| AXGN Axogen | Reiterated: Buy | $48 | $49.25 | -2.54% | 4 | Oct 2, 2026 | |
| BSX Boston Scientific | Rated: Hold | $50 → $48 | $42.43 | +13.13% | 52 | Sep 24, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $18 | $20.40 | -11.76% | 60 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 80.29 → CHF 71.18 | CHF 57.64 | +23.49% | 34 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $304.00 | +14.47% | 41 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $66 → $61 | $59.41 | +2.68% | 45 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 | $94.78 | +9.73% | 91 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $21.91 | +50.62% | 6 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $19.21 | +35.35% | 5 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 | $75.82 | +12.11% | 29 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 → $39 | $59.10 | -34.01% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.10 | +162.30% | 5 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $12.93 | +46.95% | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $99 | $81.26 | +21.83% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $4.90 | +83.67% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $103 | $96.39 | +6.86% | 43 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $11.45 | +22.27% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $255 → $144 | $148.93 | -3.31% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $70.97 | -21.09% | 39 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $318.31 | +17.50% | 48 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $74 → $83 | $92.21 | -9.99% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $46 | $45.76 | +0.52% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $138 → $178 | $181.43 | -1.89% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 → $27 | $19.68 | +37.20% | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $81.85 | -14.48% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $116 → $138 | $138.98 | -0.71% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $14.17 | +19.97% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $84 | $126.55 | -33.62% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $91.78 | +8.96% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $184 → $157 | $195.16 | -19.55% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $280 → $270 | $250.17 | +7.93% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $19 | $25.46 | -25.37% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.52 | +19.05% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7846 | n/a | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $100.10 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $8.10 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $156.08 | n/a | 1 | Jan 4, 2010 |
Beta Bionics
Oct 28, 2026
Reiterated: Buy
Price Target: $28
Current: $17.85
Upside: +56.86%
Abbott Laboratories
Oct 23, 2026
Reiterated: Buy
Price Target: $112 → $120
Current: $102.64
Upside: +16.91%
Integra LifeSciences Holdings
Oct 22, 2026
Rated: Hold
Price Target: $15 → $13
Current: $12.24
Upside: +6.21%
Intuitive Surgical
Oct 21, 2026
Rated: Buy
Price Target: $487 → $486
Current: $444.18
Upside: +9.42%
Johnson & Johnson
Oct 15, 2026
Reiterated: Buy
Price Target: $282 → $287
Current: $271.04
Upside: +5.89%
Kestra Medical Technologies
Oct 15, 2026
Reiterated: Buy
Price Target: $28
Current: $29.87
Upside: -6.26%
DexCom
Oct 14, 2026
Reiterated: Buy
Price Target: $90
Current: $78.62
Upside: +14.47%
Axogen
Oct 2, 2026
Reiterated: Buy
Price Target: $48
Current: $49.25
Upside: -2.54%
Boston Scientific
Sep 24, 2026
Rated: Hold
Price Target: $50 → $48
Current: $42.43
Upside: +13.13%
Bausch + Lomb
Sep 18, 2026
Reiterated: Hold
Price Target: $18
Current: $20.40
Upside: -11.76%
Sep 18, 2026
Reiterated: Buy
Price Target: CHF 80.29 → CHF 71.18
Current: CHF 57.64
Upside: +23.49%
Sep 16, 2026
Rated: Buy
Price Target: $348
Current: $304.00
Upside: +14.47%
Sep 9, 2026
Reiterated: Hold
Price Target: $66 → $61
Current: $59.41
Upside: +2.68%
Sep 9, 2026
Reiterated: Buy
Price Target: $104
Current: $94.78
Upside: +9.73%
Sep 8, 2026
Reiterated: Buy
Price Target: $33
Current: $21.91
Upside: +50.62%
Sep 8, 2026
Reiterated: Buy
Price Target: $26
Current: $19.21
Upside: +35.35%
Aug 25, 2026
Rated: Buy
Price Target: $85
Current: $75.82
Upside: +12.11%
Aug 14, 2026
Rated: Buy
Price Target: $37 → $39
Current: $59.10
Upside: -34.01%
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $6.10
Upside: +162.30%
Aug 12, 2026
Rated: Buy
Price Target: $19
Current: $12.93
Upside: +46.95%
Aug 7, 2026
Reiterated: Buy
Price Target: $103 → $99
Current: $81.26
Upside: +21.83%
Aug 6, 2026
Reiterated: Hold
Price Target: $9
Current: $4.90
Upside: +83.67%
Aug 6, 2026
Rated: Hold
Price Target: $90 → $103
Current: $96.39
Upside: +6.86%
Aug 5, 2026
Reiterated: Buy
Price Target: $28 → $14
Current: $11.45
Upside: +22.27%
Aug 5, 2026
Downgraded: Hold
Price Target: $255 → $144
Current: $148.93
Upside: -3.31%
Aug 4, 2026
Reiterated: Hold
Price Target: $56
Current: $70.97
Upside: -21.09%
Aug 3, 2026
Reiterated: Hold
Price Target: $374
Current: $318.31
Upside: +17.50%
Jul 31, 2026
Rated: Hold
Price Target: $74 → $83
Current: $92.21
Upside: -9.99%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $46
Current: $45.76
Upside: +0.52%
Jul 30, 2026
Rated: Buy
Price Target: $138 → $178
Current: $181.43
Upside: -1.89%
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $19.68
Upside: +37.20%
May 22, 2026
Reiterated: Hold
Price Target: $70
Current: $81.85
Upside: -14.48%
May 8, 2026
Reiterated: Hold
Price Target: $116 → $138
Current: $138.98
Upside: -0.71%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $14.17
Upside: +19.97%
Feb 20, 2026
Reiterated: Hold
Price Target: $80 → $84
Current: $126.55
Upside: -33.62%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $91.78
Upside: +8.96%
Feb 10, 2026
Reiterated: Hold
Price Target: $184 → $157
Current: $195.16
Upside: -19.55%
Jan 30, 2026
Reiterated: Hold
Price Target: $280 → $270
Current: $250.17
Upside: +7.93%
Dec 12, 2025
Reiterated: Hold
Price Target: $24 → $19
Current: $25.46
Upside: -25.37%
Nov 13, 2025
Reiterated: Hold
Price Target: $3
Current: $2.52
Upside: +19.05%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.7846
Upside: n/a
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $100.10
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $8.10
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $156.08
Upside: n/a